MMMohammadreza Mobinizadeh

Mohammadreza Mobinizadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammadreza Mobinizadeh has a total of 125 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrating Multi-Source Qualitative Data Using Causal Loop Diagrams: A Methodological Framework for Developing Systems Thinking

    by Maryam Babaei Aghbolagh, Farnoosh Azizi, Aida Asghari, Efat Mohamadi, Mohammadreza Mobinizadeh, Hakimeh Mostafavi, Alireza Olyaeemanesh

    Health systems, as complex adaptive systems, are influenced by the intertwined interactions among various actors and policies interactions that often defy explanation through linear analytical approaches. This article presents the methodological framework that integrates multi-source qualitative data through the use of system dynamics causal loop diagrams, thereby enabling the researcher to progressively develop and refine a systems-thinking perspective. Qualitative data were obtained from four sources: a literature review, semi-structured interviews with managers and experts, analysis of official documents from Social Security Organization of Iran, and an expert panel. Each method made a distinct contribution to shaping the dimensions of systems thinking: The literature review contributed to identifying key variables and shaping the initial model; document analysis supported understanding the organizational structure and further contextualizing the model; interviews enabled the discovery of organizational behavior as well as nonlinear and delayed relationships; and the expert panel facilitated the uncovering of hidden drivers underlying system behavior. The proposed “Integrating Qualitative Data for Systems Thinking” (IQDST) framework demonstrated that the convergence of these diverse data sources enabled a transition in the researcher’s analytical perspective, from descriptive analysis to structural and institutional analysis, while also identifying complex feedback loops. This article highlights that, structured integration of diverse qualitative data sources not only enriches conceptual models and enhances the ability to anticipate indirect and long-term consequences of policies but also serves as an effective mechanism for strengthening researchers’ systems thinking capacity during model development processes.

  • Orphan medicine policy and decision-making frameworks: A narrative review of HTA methodologies

    by Mohammadreza Mobinizadeh, William V. Padula, Min-Hua Jen, Efat Mohamadi, Sahar Salehi

  • Open Access

    Comparison of nursing services and consumable costs with tariffs in selected hospitals in 2022

    by Zeinab Fakoorfard, Elham Ehsani-Chimeh, Alireza Olyaeemanesh, Mani Yousefvand, Saeed Manavi, Soheila Damiri, Ebrahim Hassan-Zadeh, Maryam Radinmaneh, Amin Adel, Ali Akbarisari, et al.

    Objective(s): A portion of the financial resources for consumables which are used in inpatient departments in hospitals is entitled nursing services. The tariff of these services currently account for 6%, 4.2%, and 12% of the total income of general, intensive, and burn beds, respectively. This study aimed to compare the costs ...

  • Open Access

    Developing the Iranian health insurance benefit optimization model – the IR-HIBOM: a multicriteria decision analysis with decision rules for designing basic health insurance benefit packages

    by Ali Darvishi, Ali Akbari Sari, Mehdi Yaseri, Mohammadreza Mobinizadeh, Rajabali Daroudi

    Objectives: Prioritization of health technologies for insurance coverage is usually based on explicit and implicit criteria. This study presents the development of the multi-criteria decision analysis (MCDA) model, the Iranian Health Insurance Benefit Optimization Model (IR-HIBOM), to inform the design of basic health insurance benefit packages. Methods: An initial set of twenty-nine potential allocation criteria was identified through a review of available evidence and other relevant literature. Review of this set by three specialized panels yielded a final set of thirteen criteria. A cross-sectional survey using the best–worst scaling method was then fielded to 163 health system experts to evaluate their preferences regarding the relative importance of the allocation criteria. The mixed logit method was employed to determine the weight of the relative importance of each criterion. Subsequently, a multilevel criteria scoring framework was defined based on a review of similar models and input from a panel of five expert members of the study team. Finally, model’s appraisal was conducted. Results: Thirteen criteria, including relative safety, efficacy, disease severity, access to alternative health technologies, budget impacts, cost-effectiveness, quality of evidence, population size, age, job absenteeism, economic status, daily care needs, and ease-of-use/acceptance were selected. Cost-effectiveness and ease-of-use criteria had the highest and lowest relative importance weights, with 30.5 percent and 1 percent, respectively. Furthermore, scores were determined for the several levels of each criterion, and decision rules were defined for the cost-effectiveness and budget impact criteria. The final model’s appraisal, based on weighted scores of thirteen selected technologies, indicated that it was valid and applicable. Conclusions: The IR-HIBOM demonstrated its potential utility in the health resource allocation.


  • Open Access

    Prioritizing implementation solutions for the urban family physician policy in Iran: a multi-criteria decision-making study

    by Lida Shams, Mohammadreza Mobinizadeh, Taha Nasiri, Fatemeh Mohammadi

    Family physician program is one of the effective reforms of the health system in Iran, but despite the implementation of this program in rural areas and the passage of ten years since its implementation in two provinces of Fars and Mazandaran, its implementation has faced problems. The aim of this study is to identify and prioritize implementation solutions related to the challenges of the family physician program in Iran. This is a qualitative study using semi-structured interviews with 22 snowball-sampled experts and managers of basic health insurers to extract problems and executive solutions through coding and data analysis using Atlas Ti software and content analysis in the first stage. The combined criteria were used to report qualitative studies (COREQ). In the second stage, the extracted executive solutions were ranked using multi-criteria decision-making (MADM) and a hybrid approach combining Shannon entropy with simple aggregation weighting (SAW). Main themes were identified, including financing, management, human resources, structure, culture building, payment mechanism information systems, monitoring & control, performance of insurance organisations, and implementation. Out of these, priority was given to the information system, along with 41 sub-themes prioritising comprehensive, community-oriented physician training. The findings of the study provide remedies for the problems of the Iranian Urban Family Physician Programme at the executive level and in priority order, from the standpoint of the insurance organisations. Making crucial decisions entails handling matters relating to funding, administration, personnel, architecture, ethos, remuneration, IT systems, oversight, insurance organization output, and execution.


  • Open Access

    The New Model of Prioritizing Orphan Drugs: The Case Study for Hemophilia, SMA, CF and MS

    by Marita Mohammadshahi, Zahra Gharib-Naseri, Mohammadreza Mobinizadeh, Zeinab Fakoorfard, Farhad Hosseinzadeh Lotfi, Hamid Sharafi, Parisa Abooee, Ali Akbari Sari, Alireza Olyaeemanesh

    Background: Rare diseases, characterized by low prevalence and high complexity, pose significant challenges to health systems due to the uncertainty surrounding the best diagnostic methods and availability of effective treatments. Objectives: This study aimed to introduce new methods for prioritizing orphan drugs, with a pilot application to hemophilia, spinal muscular atrophy (SMA), cystic fibrosis (CF), and multiple sclerosis (MS). Methods: This quantitative research, conducted at Iran’s National Institute for Health Research from 2021 to 2023, employs multi-criteria decision-making models (MCDA) to evaluate the efficacy of health care technologies for "rare and hard to cure" diseases. A preliminary model was developed based on a pilot selection of seven medications, for which comprehensive data was extracted. The clinical efficacy was assessed using quality adjusted life years (QALY) as a metric. The model design was grounded on three critical factors: The annual cost of intervention per individual, the annual number of eligible patients for intervention, and the Proportion of expenses covered by the governmental budget. Additionally, the model incorporated various constraints and a regulatory coefficient, denoted as “w,” to enhance its robustness. Results: By running the model, the coverage of selected medications through model optimization, revealing the following percentages: Alemtuzumab (30%), ocrelizumab (30%), emicizumab (6%), dornase alfa (29%), tobramycin (2%), and spinraza (0.02%). Additionally, the corresponding monetary coverage in Iranian Rials is reported as follows: Alemtuzumab (27,144,000,000 IRR), ocrelizumab (109,645,200,000 IRR), emicizumab (17,360,490,000 IRR), dornase alfa (43,350,930,000 IRR), tobramycin (1,268,505,000 IRR), and spinraza (350,000,000 IRR). Conclusions: This model has tried to solve the shortcomings of the existing models regarding the prioritization of orphan drugs by combining different factors to improve access to essential treatments for rare diseases, although it can be generally asserted that no unique model can answer all policymakers’ questions regarding budget allocation of rare diseases and orphan products.

  • Open Access

    Can SMA Innovative Treatments Be Reimbursed? A Rapid Review

    by Fateme Yaftian, Mohammadreza Mobinizadeh, Alireza Olyaeemanesh, Efat Mohamadi, Farhad Habibi

    Context: Spinal muscular atrophy (SMA) is a rare genetic disorder that significantly impacts the quality of life. This paper aims to gather current understanding of the safety, efficacy, and economic aspects of common SMA treatments to assist Iranian policymakers in adopting these novel treatments for this vulnerable population. Methods: This rapid health technology assessment (HTA) research was conducted in four steps: Database review, screening, data extraction, and thematic analysis. Inclusion criteria consisted of studies focused on assessing the safety, efficacy, and economic aspects of medical interventions in SMA patients compared to those who did not receive such interventions. Results: Based on current data, nusinersen was found to be the most effective treatment (increasing mobility achievements in SMA types 1 and 2) with the least side effects for SMA types 1 and 2. In terms of economic evaluations, none of the treatments were found to be cost-effective. Conclusions: The decision regarding reimbursement for such medical drugs should not focus solely on their cost-effectiveness but rather on creating access to essential care, meeting patient needs, and considering national budget limitations. Managed entry agreements (MEAs) are flexible tools that service providers or payers can use to negotiate and reduce the financial burden for both patients and payers.


  • The Application of System Simulation in the Health Sector: A Rapid Review

    by Mohammadreza Mobinizadeh, Marita Mohammadshahi, Parisa Aboee, Zeinab Fakoorfard, Alireza Olyaeemanesh, Efat Mohamadi